Burning Rock Biotech Limited American Depositary Shares (BNR)
Score for how it compares with the broader market is near the top of its range, with company finances score is below the middle.
BNR scores higher than 73% of the 1,101 tickers we compare it with (Health Care).
As of 10 October 2026, Burning Rock Biotech Limited American Depositary Shares (BNR) scores 53 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.15× 30-day average
- 52-week range
- 6.79 – 41.72
- Market cap
- —
- Earnings date
- 18 Nov 2026
- Volume
- 7,699
- Avg. volume (30d)
- 52,357
- Open
- 14.79
- Previous close
- 15.49
- Day's range (regular session)
- 14.79 – 15.82
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 1.51
- P/E (TTM)
- —
- EPS (TTM)
- -0.56
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
What the score says about BNR right now
Burning Rock Biotech Limited American Depositary Shares (BNR) currently scores 53/100 on the Market Census six-factor composite, at the Average score level. BNR is +0.00% on the day and -4.68% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in BNR's data roughly balance out right now. BNR's strongest factor is strength vs the market at 100/100 — a very strong read on how BNR has done next to the wider market. It describes what has happened, not what happens next. The weakest factor is company finances at 23/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See BNR in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent BNR news
Latest headlines that name Burning Rock Biotech Limited American, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Burning Rock Reports Second Quarter 2026 Financial ResultsYahoo
- Burning Rock Biotech Q2 EPS $(0.20) Down From $(0.10) YoY, Sales $19.862M Down From $20.737M YoYBenzinga
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to BNR’s 53, all within 1 point.
Sorted by closeness to BNR’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.